This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb and Merck & Co.

Evolving Paradigms in Melanoma Therapy

Anthony J. Olszanski, MD, RPH,
Fox Chase Cancer Center

Brianna Hoffner, MS, ANP-BC, AOCNP
The Angeles Clinic and Research Institute

Learn the science behind immune response and treatment options for Melanoma. This activity provides an overview of differentiating checkpoint inhibitors from options such as kinase inhibitors, and cytotoxic chemotherapy.  Discuss potential toxicities, care management, and the AP role in the collaborative practice approach to patient care.


Download Podcast


Download Transcript


Download Slides


Download Slides & Transcripts


These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.